glyoxal has been researched along with losartan potassium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, W; Shen, J; Sinclair, SH; Wu, Y; Xu, G; Xu, GT; Xu, JY; Yanoff, M; Zhang, J | 1 |
1 other study(ies) available for glyoxal and losartan potassium
| Article | Year |
|---|---|
ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.
Topics: Animals; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; bcl-Associated Death Protein; bcl-X Protein; Blotting, Western; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Erythropoietin; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Glycation End Products, Advanced; Glyoxal; In Situ Nick-End Labeling; Male; Neuroprotective Agents; Organ Culture Techniques; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Retinal Neurons; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Up-Regulation | 2010 |